Feng Liu

Company: Regor Therapeutics

Job title: Executive Director, Research & Development

Seminars:

Mitigating the Need for Peptide Production with Small Molecule GLP-1 Receptor Agonists: Balancing Pharmacokinetics with Efficacy 3:40 pm

Exploring the benefits of small molecule GLP-1 receptor agonists over injectable peptide-based therapeutics Navigating differential efficacy and safety profiles compared to peptide-based therapeutics from biological stability to receptor selectivity Exploring the differential pharmacokinetic profile and key considerations for developmentRead more

day: Conference Day One

Panel Discussion: The Obesity Race on the Manufacturing Floor – Exploring Supply Challenges with Innovations in Discovery 2:10 pm

Examining supply chain challenges associated with peptides, including raw material shortages and complex manufacturing processes, and how these impact the availability of GLP-1 drugs compared to other therapeutic classes Analyzing the disparity between the rapidly increasing demand for GLP-1 receptor agonists and the current manufacturing capacity, highlighting how this affects market supply and patient access…Read more

day: Conference Day One